Articles on COVID-19
Important paper on COVID-19 Impacts on US Supply and Demand (by Doyne Farmer, et al; Oxford Univ.)
Important paper on COVID-19 Impacts on US Supply and Demand (by Doyne Farmer, et al; Oxford Univ.)
Important paper on COVID-19 Impacts on US Supply and Demand (by Doyne Farmer, et al; Oxford Univ.)
Important modeling and policy recommendations re: the economic impacts on US supply and demand chain disruptions from COVID-19.
Impacts on Poor Countries; Duration; Testing (Fareed's Global Briefing 4-15-2020)
Important paper on COVID-19 Impacts on US Supply and Demand (by Doyne Farmer, et al; Oxford Univ.)
Important paper on COVID-19 Impacts on US Supply and Demand (by Doyne Farmer, et al; Oxford Univ.)
The impacts of quarantine may be more damaging to poor countries than COVID-19 is. Effective social distancing prevents herd immunity so COVID-19 resurgence could be a problem into 2020. Need for massive testing. COVID-19 side-effect impacts.
former FDA commissioner Scott Gottlieb on steps to re-starting the economy (4-14-20)
former FDA commissioner Scott Gottlieb on steps to re-starting the economy (4-14-20)
former FDA commissioner Scott Gottlieb on steps to re-starting the economy (4-14-20)
Gottlieb lays out his view for gradual re-introduction of limited social activity, testing and the challenges of scaling up, prospects for near-term medical therapeutics, the need for extended social distancing among vulnerable people, the 80% economy and more.
EIDD-2801 antiviral drug in clinical trials
former FDA commissioner Scott Gottlieb on steps to re-starting the economy (4-14-20)
former FDA commissioner Scott Gottlieb on steps to re-starting the economy (4-14-20)
In human lung cell cultures and in animal testing, an RNA polymerase inhibitor, EIDD-2801 showd impressive ability to block replication in the SARS-CoV-2 virus. Unlike Remdesivir which must be given IV, this inhibitor can be administered orally which makes it far more practical to deploy. With potential as a prophylactic AND a treatment human clinical trials should start this spring.
links to covid-19 resources
Projected Hospitalizations and Fatalities- (University of Washington IHME)
Projected Hospitalizations and Fatalities- (University of Washington IHME)
Projected Hospitalizations and Fatalities- (University of Washington IHME)
The best modeling for the expected impact. Scroll down from the US menu to select individual states
CDC COVID-19 Information Website
Projected Hospitalizations and Fatalities- (University of Washington IHME)
Projected Hospitalizations and Fatalities- (University of Washington IHME)
Info on symptoms, prevention, cases and everything; from the national Center for Disease Control (CDC)
Graphs of COVID-19 Cases by Country (Euro CDC)
Projected Hospitalizations and Fatalities- (University of Washington IHME)
Graphs of COVID-19 Cases by Country (Euro CDC)
A very useful interactive map, updated daily, of new cases in each country. crucial for monitoring how different countries are making progress in rate and number of infections.
Maine CDC
IO21 Urban COVID Vulnerability
Graphs of COVID-19 Cases by Country (Euro CDC)
Info on cases, testing, and many more topics of use to people in Maine
IO21 Urban COVID Vulnerability
IO21 Urban COVID Vulnerability
IO21 Urban COVID Vulnerability
Interactive map of US cities indexed to level of exposure to COVID-19